化学发光免疫分析 (CLIA) 市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

化学发光免疫测定 (CLIA) 市场按产品类型(分析仪、试剂和耗材)、应用、最终用户和地理区域划分

化学发光免疫分析 (CLIA) 市场快照

chemiluminescence immunoassay market share
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.6 %
chemiluminescence immunoassay market key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计化学发光免疫分析 (CLIA) 市场在预测期内将以 6.6% 的复合年增长率增长。化学发光免疫分析 (CLIA) 市场增长的主要因素是心血管疾病、糖尿病、自身免疫性疾病、癌症等慢性病发病率的上升。

患有慢性病的人口增加正在推动市场增长。心脏病仍然是美国的主要死因。2018 年,根据 AHA 的统计数据,大约 720,000 名美国人经历了冠状动脉事件,大约 335,000 人经历了反复发作的事件。在将化学发光免疫分析 (CLIA) 市场推向新的水平方面发挥关键作用的因素很少,其中之一是与化学发光分析仪及其技术相关的持续发展,预计将进一步推动全球增长化学发光免疫分析(CLIA)市场。

报告范围

根据报告的范围,化学发光 (CL) 被描述为由于化学反应产生光而产生的电磁辐射放电。化学发光免疫测定法 (CLIA) 是一种将化学发光技术与免疫化学反应相结合的测定法。

By Product Type
Analyzers
Automated
Semi-Automated
Reagents
Luminophore Markers
Enzymatic Markers
Consumables
By Application
Oncology
Autoimmune Disorder
Infectious Disease
Cardiovascular Disease
Endocrine Disorders
Others
By End User
Pharmaceutical and Biotechnology Companies
Hospital and Clinical Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

试剂部门预计将在化学发光免疫分析 (CLIA) 市场中占有最大的市场份额

由于与分析仪系统相比,试剂更换频率相对较高,预计试剂部分将在预测期内继续占据主导地位。

根据 GLOBOCAN 2018 的统计数据,全球有 18,078,957 人患有癌症。亚洲仍然是癌症发病率上升的主要贡献者,据报道份额为 48.4%,其次是欧洲、北美和拉丁美洲、非洲和大洋洲,分别为 23.4%、13.2%、7.8%、5.8% 和 1.4% % 分别。

因此,对超灵敏疾病诊断、更好的准确性和质量的需求不断增加,以及有望推动试剂市场的新测试选项的不断发展。特别是对癌症、心血管和其他慢性疾病的高内涵诊断和临床研究的需求不断增加,也正在加强试剂的市场增长。

chemiluminescence immunoassay market trends

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个化学发光免疫分析 (CLIA) 市场。这是由于心血管疾病和癌症等慢性病发病率上升等因素,而测试产品的革命是主要因素之一。 

在北美地区,由于心血管疾病和其他慢性病患者人数不断增加等因素,美国拥有最大的市场份额。根据美国疾病控制与预防中心 (CDC) 和美国心脏协会 (AHA) 的说法,冠心病是美国死亡的主要原因,并伴有中风、高血压、冠心病、心力衰竭和其他心血管疾病。然而,该国不断增长的老年人口和与化学发光免疫分析(CLIA)相关的发展,也将有助于刺激该地区对 CLIA 的需求。

chemiluminescence immunoassay market analysis

竞争格局

化学发光免疫分析 (CLIA) 市场竞争适度,由主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。一些知名企业正积极与其他公司进行收购和新产品发布,以巩固其在全球的市场地位。目前主导市场的一些公司包括 F. Hoffmann-La Roche AG、Mindray Medical International Limited、Siemens Healthcare GmbH、Beckman Coulter Inc.(Danaher Corporation)和 DiaSorin SpA

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Chronic Diseases

      2. 4.2.2 Increasing Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Scarcity of Skilled Labor and Healthcare Professionals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Analyzers

        1. 5.1.1.1 Automated

        2. 5.1.1.2 Semi-Automated

      2. 5.1.2 Reagents

        1. 5.1.2.1 Luminophore Markers

        2. 5.1.2.2 Enzymatic Markers

      3. 5.1.3 Consumables

    2. 5.2 By Application

      1. 5.2.1 Oncology

      2. 5.2.2 Autoimmune Disorder

      3. 5.2.3 Infectious Disease

      4. 5.2.4 Cardiovascular Disease

      5. 5.2.5 Endocrine Disorders

      6. 5.2.6 Others

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Hospital and Clinical Laboratories

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 F. Hoffmann-La Roche AG

      2. 6.1.2 Mindray Medical International Limited

      3. 6.1.3 Siemens Healthcare GmbH

      4. 6.1.4 Beckman Coulter Inc. (Danaher Corporation)

      5. 6.1.5 DiaSorin S.p.A.

      6. 6.1.6 Sysmex Corporation

      7. 6.1.7 Randox Laboratories Ltd.

      8. 6.1.8 Tosoh Corporation

      9. 6.1.9 Shenzhen New Industries Biomedical Engineering Co., Ltd.

      10. 6.1.10 BioMerieux

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Chemiluminescence Immunoassay (CLIA) Market market is studied from 2018 - 2026.

The Chemiluminescence Immunoassay (CLIA) Market is growing at a CAGR of 6.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

F. Hoffmann-La Roche AG, Mindray Medical International Limited, Siemens Healthcare GmbH, Beckman Coulter Inc. (Danaher Corporation), DiaSorin S.p.A. are the major companies operating in Chemiluminescence Immunoassay (CLIA) Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!